Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |